Literature DB >> 17566848

Granulosa cell tumor associated with secondary amenorrhea and serum luteinizing hormone elevation.

Kaei Nasu1, Junichiro Fukuda, Jun Yoshimatsu, Noriyuki Takai, Kenji Kashima, Hisashi Narahara.   

Abstract

Adult granulosa cell tumors (GCTs) are the most common type of ovarian sex cord tumors. Menstrual irregularity, menorrhagia, or even secondary amenorrhea is frequently observed in premenopausal women bearing GCTs with hormonal activity. We report herein a case of GCT in a patient presenting with secondary amenorrhea and serum luteinizing hormone elevation. A 28-year-old primigravid Japanese woman was admitted complaining of secondary amenorrhea of 2 years' duration. Pelvic examination, transvaginal ultrasonography, and magnetic resonance imaging demonstrated a left ovarian tumor 4 cm in diameter. Serum hormone assays revealed a follicle-stimulating hormone level of 4.8 mIU/ml, luteinizing hormone (LH) of 35.8 mIU/ml, estradiol of 24 pg/ml, progesterone of 1.6 ng/ml, and testosterone of 40 ng/dl. A left salpingo-oophorectomy was performed. The tumor was diagnosed as an adult-type GCT stage IIb (FIGO [International Federation of Obstetricians and Gynecologists], 1988). Spontaneous menstruation occurred soon after the surgery. Serum levels of LH also decreased to normal levels and showed cyclic changes during the menstrual cycle. Subsequently, the patient conceived and delivered a healthy female baby. The tumor recurred in the pelvis 50 months after the initial conservative surgery, with elevated serum LH levels of 36.0 mIU/ml and amenorrhea. The patient was treated by hysterectomy, right salpingo-oophorectomy, omentectomy, paraaortic and pelvic lymphadenectomy, and low anterior resection of the recto-sigmoid colon. Her hormone levels progressed to the postmenopausal state after this surgery. Although LH elevation in patients with GCT is rare and its mechanism is unknown, monitoring of serum LH may provide an additional tumor marker after conservative surgery in such patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566848     DOI: 10.1007/s10147-006-0640-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  7 in total

Review 1.  Endocrine tumors of the ovary.

Authors:  R H Young; R E Scully
Journal:  Curr Top Pathol       Date:  1992

2.  Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.

Authors:  M L Gustafson; M M Lee; R E Scully; A C Moncure; T Hirakawa; A Goodman; H G Muntz; P K Donahoe; D T MacLaughlin; A F Fuller
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

Review 3.  Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans.

Authors:  Chi Keung Cheng; Peter C K Leung
Journal:  Endocr Rev       Date:  2004-11-23       Impact factor: 19.871

4.  Amenorrhoea and failure to virilize in a patient with a testosterone secreting granulosa cell tumour.

Authors:  H C Taylor; M E Velasco; S G Flores; G Berg; T R Brown
Journal:  Clin Endocrinol (Oxf)       Date:  1982-12       Impact factor: 3.478

Review 5.  Therapy of ovarian malignant germ cell tumors and granulosa tumors.

Authors:  A Pfleiderer
Journal:  Int J Gynecol Pathol       Date:  1993-04       Impact factor: 2.762

6.  Inhibin as a marker for granulosa-cell tumors.

Authors:  R E Lappöhn; H G Burger; J Bouma; M Bangah; M Krans; H W de Bruijn
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

Review 7.  Granulosa cell tumor of the ovary.

Authors:  Susan Tinsley Schumer; Stephen A Cannistra
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

  7 in total
  2 in total

1.  Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.

Authors:  Brooke S Middlebrook; Karen Eldin; Xiaohui Li; Sujatha Shivasankaran; Stephanie A Pangas
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

Review 2.  Luteinizing hormone elevation in ovarian granulosa cell tumor: a case report and review of the literature.

Authors:  Shengyuan Ran; Qi Yu; Shan Deng; Ling Xu
Journal:  J Ovarian Res       Date:  2017-04-24       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.